Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Individual enzyme-inhibitor complexes with characteristic absorption spectra have been obtained as a result of the reaction of the apoenzyme of
aspartate aminotransferase
with Nalpha-(5'-phosphopyridoxyl)-L-glutamic acid, Nalpha-(5'-phosphopyridoxyl)-D-glutamic acid, and Nalpha-(5'-phosphopyridoxyl)-L-pyroglutamic acid. The stability of the enzyme-inhibitor complexes has been investigated under various conditions, viz., reactivation by the coenzyme, denaturation by urea, variations in the pH. It has been shown that the complexes formed by the last two inhibitors are reactivated by pyridoxal-5'-phosphate and that the inhibitor can be released under mild conditions. The enzyme-inhibitor complex formed by Nalpha-(5'-phosphopyridoxyl)-L-glutamic acid, on the other hand, was not reactivated by the coenzyme. Pyridoxylglutamic acid has been isolate in attempts to release the inhibitor. The dephosphorylation of the inhibitor has been associated both with the hydrolysis of a phosphate bond involving the enzyme and with the phosphorylation of
aspartate aminotransferase
. A 32P peptide containing 13 amino acids has been isolated from the tryptic hydrolysate of the enzyme-inhibitor complex (formed by a 32P inhibitor). The data obtained have been interpreted on the basis of an assumption that the phosphate group of the coenzyme has an active role in the enzymatic transamination reaction.
Mol
Biol (Mosk)
PMID:Labilization of the phosphoester linkage in enzyme-inhibitor complexes of aspartate aminotransferase. 1 13
Rose-bengal-sensitized photooxidation of
aspartate transaminase
from chicken heart cytosol results in a loss of enzymatic activity which follow first order kinetics down to 70--75% inactivation. 0.9 Histidine, 0.9 tryptophane residues and 1.5 SH groups per enzyme subunit were found to be modified in the photooxidized transaminase, which retained 26% residual activity. Photodestruction of the coenzyme was about 16%. The rate of enzyme photoinactivation is constant in the pH range 6--8, and drastically decreases with lowering pH from 6 to 4. alpha-Ketoglutarate partially protects the holoenzyme from inactivation. The apoenzyme undergoes photoinactivation at a rate almost twice as rapid as the holoenzyme. Photooxidized apotransaminase retains affinity to pyridoxal phosphate and binds as much coenzyme as the native apoenzyme. Photooxidation induces no significant alterations in the circular dichroism pattern of the enzyme in the 200 to 240 nm range. However, positive circular dichroism is markedly increased in the absorption bands of aromatic amino acids (260--300 nm). The affinity of photooxidized holoenzyme for glutarate and alpha-methyl aspartate is greatly decreased. On the other hand, photooxidized enzyme retains its ability to bind alpha-alanine and to catalize the transamination half-reaction between alpha-alanine and the bound coenzyme. These findings imply that photooxidation disturbs the binding of the distal carboxyl group of dicarboxylic substrates. This may be due to a localized conformational change induced by destruction of a photoreactive histidine residue at the active site. A role of the histidine residue in transamination reaction is discussed.
Mol
Biol (Mosk)
PMID:[Photooxidation of aspartate transaminase from chicken heart cytosol]. 3 52
Spin-labeled analogues of vitamin B6: 2, 2, 6, 6-tetramethyl-N-oxylpiperydinyl-4-(5' phosphopyridoxyl)-amine (1) and 2, 2, 6, 6-tetramethyl-N-oxyl-piperydinyl-4-(pyridoxal-5')-phosphate (II) are synthesized. There analogues were shown to interact in the equimolar ratio with the active site of cytosol
aspartate transaminase
. It was proved by CD-titration of apotransaminase with I and II and by competition between the coenzyme and synthesized analogues. The free valency of spin-labeled coenzymes immediately disappears after interaction with the apoenzyme due to iminoxyl group reduction. The binding of I and II with the apoenzyme is accompanied by oxidation of one of the inner cysteine residues. The reactivation of the modified apoenzyme with PLP is not less than 65% of original transaminase activity. The analysis of space-filling atomic models of synthesized compounds allows to conclude that the distance between the centre of pyridine ring of the coenzyme and the modified thiol group is not more than 8 A.
Mol
Biol (Mosk)
PMID:[Interaction of spin-labeled analogues of vitamin B 6 with the active site of apotransaminase]. 17 69
Holo and apoenzyme of
aspartate aminotransferase
from beef kidney are 80% inactivated by photoxidation in the presence of 2 X 10(-6) M tetraiodofluroescein with the modification of two histidine residues per enzyme protomer. At a higher concentration (1 X 10(-5) M) a tyrosine residue is also modified. The keto substrates, ketoglutarate and oxalacetate, protect the enzyme from photoxidation. Diethylpyrocarbonate modifies three histidine residues per enzyme protomer and reduces the activity only 10%. These results suggest that the two histidine residues photoxidized through the sensitizer, are located in the active site of the enzyme, at least one of these appears to be involved in ketosubstrate binding. The other three histidines modified by diethylpyrocarbonate are likely located on the enzyme surface and are not involved in the catalytic activity of the enzyme.
Mol
Cell Biochem 1976 Jun 15
PMID:Chemical modifications of histidine residues in cytoplasmic asparate aminotransferase from beef kidney. 94 May 48
Changes of quaternary structure and conformation of molecule concomitant with inactivation were observed in the course of
aspartate transaminase
acylation by maleic, citraconic, dimethylmaleic and succinic anhydrides. It was established that acylation of 10-12 xi-amino groups of lysine did not induce the dissociation of transaminase into subunits. Further acylation of amino groups (2 groups if dimethylmaleic anhydrade was used as acylating agent) induced dissociation of transaminase dimer into subunits. These data were obtained by sedimentation analysis. The dissociation was accompanied with a sharp decrease of correlation time (from 18 nsec to 9 nsec) of the paramagnetic label covalently bound to the protein. The obtained results allow us to distinguish three types of xi-aminogroups of
aspartate transaminase
: exposed (about 12 residues), "contact" (2 residues) located in the vicinity to complementary surfaces of subunits and buried (about 6 residues). The stepwise inactivation occurred during the acylation as a result of conformational changes or appearance of sterical hindrances in the cataytic site of the enzyme. The thiol groups were not modified in transaminase molecule under experimental conditions used. Aspartate transaminase treated with citraconic or dimethylmaleic anhydride may be deacylated under mild conditions. After reacylation the quaternary structure was reconstituted and catalytic activity was almost fully restored.
Mol
Biol (Mosk)
PMID:[The effect of various acylating agents on the catalytic properties and structure of aspartate aminotransferase]. 121 97
Cytoplasmic
aspartate aminotransferase
from beef kidney loses 25% of its activity on nitration with tetranitromethane while the apoenzyme about 95%. In the holoenzyme 0.5 tyrosine residue and 1.0 tyrosine residue in the apoenzyme are nitrated per enzyme protomer. In addition 1 cysteine residue per protomer is oxidized in both. The presence of substrates, alpha-ketoglutarate and glutamate, both at ten times their Km values, does not change these results. Mercaptoethanol does not affect the residual activity of either the nitrated holo or apoenzyme. Dithionite abolishes the activity of the nitrated holoenzyme by reducing tha coenzyme moiety. It has no effect on the native holoenzyme or on either the native or nitroapoenzyme.
Mol
Cell Biochem 1976 Apr 28
PMID:Role of tyrosine residues in cytoplasmic aspartate aminotransferase from beef kidney. 127 58
Prolactin (PRL) has been reported to stimulate citrate production and the activity of mitochondrial
aspartate aminotransferase
(mAAT) and its precursor form pmAAT in prostate epithelial cells. The phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) caused the same result as PRL, which suggests that the PRL effect on mAAT activity might be mediated by protein kinase C (PKC) stimulation of pmAAT gene transcription. Both PRL and TPA increased the level of pmAAT mRNA by 2.5- to 3-fold in pig prostate cells. The PKC inhibitor gossypol completely inhibited the PRL and TPA induced increases. In addition, the effects of both PRL and TPA were inhibited by down-regulation of prostate PKC. Nuclear run-off assays indicated that PRL and TPA induction of pmAAT occurred primarily at the transcriptional level. The stimulation of pmAAT transcription by TPA suggests that the pmAAT gene contains a TPA response element. Thus, these results are consistent with our previous observation that PRL directly induces pmAAT and that the mechanism of this PRL effect might involve stimulation of PKC.
Mol
Cell Endocrinol 1992 Dec
PMID:Prolactin stimulates transcription of aspartate aminotransferase in prostate cells. 130 96
The crystals of free cytosolic chicken
aspartate aminotransferase
were subjected to X-ray investigation at 2.7 A. One subunit of the dimeric molecule crystalline enzyme is in the open conformation and the other is in the closed conformation.
Mol
Biol (Mosk)
PMID:[Crystals of free aspartate aminotransferase]. 143 76
The subunits of the dimeric enzyme
aspartate aminotransferase
have two domains: one large and one small. The active site lies in a cavity that is close to both the subunit interface and the interface between the two domains. On binding the substrate the domains close together. This closure completely buries the substrate in the active site and moves two arginine side-chains so they form salt bridges with carboxylate groups of the substrate. The salt bridges hold the substrate close to the pyridoxal 5'-phosphate cofactor and in the right position and orientation for the catalysis of the transamination reaction. We describe here the structural changes that produce the domain movements and the closure of the active site. Structural changes occur at the interface between the domains and within the small domain itself. On closure, the core of the small domain rotates by 13 degrees relative to the large domain. Two other regions of the small domain, which form part of the active site, move somewhat differently. A loop, residues 39 to 49, above the active site moves about 1 A less than the core of the small domain. A helix within the small domain forms the "door" of the active site. It moves with the core of the small domain and, in addition, shifts by 1.2 A, rotates by 10 degrees, and switches its first turn from the alpha to the 3(10) conformation. This results in the helix closing the active site. The domain movements are produced by a co-ordinated series of small changes. Within one subunit the polypeptide chain passes twice between the large and small domains. One link involves a peptide in an extended conformation. The second link is in the middle of a long helix that spans both domains. At the interface this helix is kinked and, on closure, the angle of the kink changes to accommodate the movement of the small domain. The interface between the domains is formed by 15 residues in the large domain packing against 12 residues in the small domain and the manner in which these residues pack is essentially the same in the open and closed structures. Domain movements involve changes in the main-chain and side-chain torsion angles in the residues on both sides of the interface. Most of these changes are small; only a few side-chains switch to new conformations.(ABSTRACT TRUNCATED AT 400 WORDS)
J
Mol
Biol 1992 Sep 05
PMID:Domain closure in mitochondrial aspartate aminotransferase. 152 85
The X-ray crystal structures of three forms of the enzyme
aspartate aminotransferase
(EC 2.6.1.1) from chicken heart mitochondria have been refined by least-squares methods: holoenzyme with the co-factor pyridoxal-5'-phosphate bound at pH 7.5 (1.9 A resolution), holoenzyme with pyridoxal-5'-phosphate bound at pH 5.1 (2.3 A resolution) and holoenzyme with the co-factor pyridoxamine-5'-phosphate bound at pH 7.5 (2.2 A resolution). The crystallographic agreement factors [formula: see text] for the structures are 0.166, 0.130 and 0.131, respectively, for all data in the resolution range from 10.0 A to the limit of diffraction for each structure. The secondary, super-secondary and domain structures of the pyridoxal-phosphate holoenzyme at pH 7.5 are described in detail. The surface area of the interface between the monomer subunits of this dimeric alpha 2 protein is unusually large, indicating a very stable dimer. This is consistent with biochemical data. Both subunit and domain interfaces are relatively smooth compared with other proteins. The interactions of the protein with its co-factor are described and compared among the three structures. Observed changes in co-factor conformation may be related to spectral changes and the energetics of the catalytic reaction. Small but significant adjustments of the protein to changes in co-factor conformation are seen. These adjustments may be accommodated by small rigid-body shifts of secondary structural elements, and by packing defects in the protein core.
J
Mol
Biol 1992 May 20
PMID:X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. 159 33
1
2
3
4
5
6
7
8
9
10
Next >>